500 COPD patients to be tracked for 3 years to uncover hidden disease patterns

NCT ID NCT07627763

Recruiting now Knowledge-focused Sponsor: Initiatives Bronchopneumopathie Chronique Obstructive (BPCO) Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study will follow 500 adults with stable COPD for at least 3 years to identify and describe different patient profiles. Researchers will use routine care data to group patients by their characteristics, treatments, and outcomes. The goal is to better understand the various forms of COPD and compare them with profiles from a similar study done between 2005 and 2018.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this study could help doctors better understand different types of COPD and tailor treatments to individual patients.
What could go wrong: This is an observational study, not a treatment trial. It cannot prove that any specific approach works, and results may not lead to immediate changes in care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC OBSTRUCTIVE PULMONARY DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic obstructive pulmonary disease COPD, severe early onset Dyspnea

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

COPD

Contacts and locations

Locations

Chu Bordeaux
RECRUITING

Bordeaux, France
Chu Lille
RECRUITING

Lille, France
Chu Lille
RECRUITING

Lille, France
Chu Nancy-Brabois
RECRUITING

Nancy, France
Chu Reims
RECRUITING

Reims, France
Chu Saint Etienne
RECRUITING

Saint-Etienne, France
Hopital Cochin
RECRUITING

Paris, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.